Liver transplantation for chronic viral liver disease

Hepato-Gastroenterology

Volumn 45, Issue 23, 1998, Pages 1357-1363

  Colantoni, Alessandra ^a,c   Hassanein, Tarek ^b   Idilman, Ramazan ^a   Van Thiel, David H ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b UNIVERSITY OF SAN DIEGO   (United States)

^c LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Liver; Transplantation; Viral hepatitis

Indexed keywords

ALPHA INTERFERON; FAMCICLOVIR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEPATITIS B ANTIBODY; IMMUNOSUPPRESSIVE AGENT; LAMIVUDINE; NUCLEOSIDE ANALOG; RIBAVIRIN;

ALLOGRAFT; ARTICLE; GRAFT INFECTION; GRAFT REJECTION; HEPATITIS B; HEPATITIS C; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; PRIORITY JOURNAL; RECURRENT INFECTION; TIME; VIRUS HEPATITIS; VIRUS LOAD; VIRUS REPLICATION;

HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HEPATITIS, CHRONIC; HEPATITIS, VIRAL, HUMAN; HUMANS; LIVER TRANSPLANTATION; RECURRENCE;

EID: 0031737033     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Marcellin P, Samuel D, Areias J, et al: Pretransplantation Interferon treatment and recurrence of hepatitis B infection after liver transplantation for hepatitis B-related end-stage liver disease. Hepatology 1994; 19:6-12.
2. Samuel D, Bismuth A, Mathieu D, et al: Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients. Lancet 1991; 337:813-815.
3. Samuel D, Feray C, Bismuth A: Hepatitis viruses and liver transplantation. J Gastroenterol Hepatol 1997; 12:S335-341.
4. Ottobrelli A, Marzano A, Smedile A, et al: Patterns of hepatitis delta virus reinfection and disease in liver transplantation. Gastroenterology 1991; 101:1649-1655.
5. Lau JYN, Bain VG, Davies SE, et al: High level expression of hepatitis B viral antigens in fibrosing cholestatic hepatitis. Gastroenterology 1992; 102:956-962.
6. Mason A, Yoffe B, Noonan C, et al: Hepatitis B virus DNA in peripheral blood mononuclear cells in chronic hepatitis B after HBsAg clearance. Hepatology 1992; 16:36-41.
7. Tur-Kaspa R, Shaul Y, Moore DD, et al: The glucocorticoid receptor recognizes a specific nucleotidic sequence in hepatitis B virus DNA causing increased activity of the HBV enhancer. Virology 1988; 167:630-633.
8. Fruman DA, Burakoff SJ, Bierer BE: Immunophillins in protein folding and immunosuppression. FASEB J 1994; 8:391-400.
9. Muller R, Gubernatis G, Farie M, et al: Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization. J Hepatol 1991; 13:90-96.
10. Wong DK, Cheung AM, O'Rourke K, Naylor CD, Detsky AS, Heathcote J: Effects of alpha-interferon treatment in patients with hepatitis B e antigen positive chronic hepatitis B: A meta-analysis. Ann Intern Med 1993; 119:312-323.
11. Martin J, Bosh J, Moraleda G, et al: Pilot study of recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of chronic hepatitis B. Hepatology 1993; 18:775-780.
12. Gish RG, Lau JY, Brooks L, et al: Ganciclovir treatment of hepatitis B virus infection in liver transplant recipients. Hepatology 1996; 23:1-7.
13. Schalm SW, de Man RA, Heijtink RA, Niesters HG: New nucleosid analogues for chronic hepatitis B. J Hepatol 1995; 22 (Suppl.1):52-56.
14. Dienstag JL, Perrillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M: A preliminary trial of lamivudine for chronic hepatitis B infection. New Engl J Med 1995; 333:1657-1661.
15. Grellier L, Mutimer D, Brown D, et al: Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet 1996; 348:1212-15.
16. Bartholomew MM, Jansen RW, Jeffers LJ, et al: Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet 1997; 349:20-22.
17. Feray C, Samuel D, Gigou M, et al: An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: antiviral effects and risk of rejection. Hepatology 1995; 22:1084-1089.
18. David E, Rahier J, Pucci A, et al: Recurrence of hepatitis D (delta) in liver transplants: Histopathological aspects. Gastroenterology 1993; 104:1122-1128.
19. Huang EJ, Wright TL, Lake JR, Combs C, Ferrell LD: Hepatitis B and C coinfection and persistent hepatitis B infections: clinical outcome and liver pathology after transplantation. Hepatology 1996; 23:396-404.
20. Fishman JA, Rubin RH, Koziel MJ, Periera BJ: Hepatitis C and organ transplantation. Transplantation 1996; 62:147-154.
21. Gane EJ, Portmann BC, Naoumov NV, et al: Long term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996; 334:815-820.
22. Boker KH, Dalley G, Bahr MJ, et al: Long term outcome of hepatitis C infection after liver transplantation. Hepatology 1997; 25:203-210.
23. Gane EJ, Naoumov NV, Qian KP, et al: A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 1996; 110:167-177.
24. Shah G, Demetris AJ, Gavaler JS, et al: Incidence, prevalence and clinical course of hepatitis C post liver transplantation. Gastroenterology 1992; 103:323-329.
25. Sherlock S: Antiviral therapy for chronic hepatitis C viral infection. J Hepatology 1995; 23 (suppl.2):3-7.